MBIO:NASDAQ
Mustang Bio Inc
$0.37
arrow_downward
-1.78%(-0.0067) 1D
$0.37
arrow_upward
+0.76% (+0.0028)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 14, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MBIO...
Buksan
$0.38
Mataas
$0.43
Mababa
$0.37
Mkt. cap
2.78M
Avg. na dami
33.20K
Dami
0.00
Mataas nang 52-wk
$1.69
Mababa nang 52-wk
$0.37
EPS
-$0.46
Beta
2.09
Mga natitirang share
6.73M
Bilang ng mga empleyado
4
Buksan
$0.38
Mataas
$0.43
Mababa
$0.37
Mkt. cap
2.78M
Avg. na dami
33.20K
Dami
0.00
Mataas nang 52-wk
$1.69
Mababa nang 52-wk
$0.37
EPS
-$0.46
Beta
2.09
Mga natitirang share
6.73M
Bilang ng mga empleyado
4
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 araw ang nakalipas
Mustang Bio stock sits 2.70 percent above its yearly low
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Tungkol sa Mustang Bio Inc
CEOManuel Litchman
Mga Empleyado4
Itinatag2015
HeadquartersWaltham, Massachusetts, Estados Unidos
Sektor-
Websitemustangbio.com